Ted Hanagan Email & Phone Number | 30 years in the Medical Device Industry 6 patents Goal is to make significant contributions to new Drug Delivery Systems at Abbott Laboratories by bringing my design, manufacturing, materials, regulatory, testing and project management experience to solve any problem or launch any new system that comes along at AbbVie. In The last 5 years I have focused on leading large cross-functional teams to complete Design Verification for device drug combinations in phase 0 - phase 3 clinical trials. Specialties: Early adopter of phenomomal e-DHF system and active member of the community of practice for the ABBVIE custom e-DHF, 3-D design, Problem solving field and manufacturing issues

Ted Hanagan

30 years in the Medical Device Industry 6 patents Goal is to make significant contributions to new D...
Libertyville, Illinois, United States

*50 free lookup(s) per month.

Ted Hanagan’s Email ted@abbvie.com

Ted Hanagan’s Phone Numbers

Get TED’s Phone Number (For Free)

Social Media

Ted Hanagan’s Location Libertyville, Illinois, United States

Ted Hanagan’s Current Industry Abbvie

Ted Hanagan’s Prior Industry Abbott Laboratories | Hospira | Abbott Laboratories Hospital Products Division

Find accurate emails & phone numbers for over 700M professionals.

Combination Device Engineer

2013-01-01 00:00:00 - Present

Senior Scientist

2010-08-01 00:00:00 - 2012-12-01 00:00:00

Sr. Development Engineer

2004-05-01 00:00:00 - 2010-08-01 00:00:00

Device Product Design

1989-01-01 00:00:00 - 1999-01-01 00:00:00

No Skills Available

No Languages Available

Ted Hanagan is a 30 years in the Medical Device Industry 6 patents Goal is to make significant contributions to new Drug Delivery Systems at Abbott Laboratories by bringing my design, manufacturing, materials, regulatory, testing and project management experience to solve any problem or launch any new system that comes along at AbbVie. In The last 5 years I have focused on leading large cross-functional teams to complete Design Verification for device drug combinations in phase 0 - phase 3 clinical trials. Specialties: Early adopter of phenomomal e-DHF system and active member of the community of practice for the ABBVIE custom e-DHF, 3-D design, Problem solving field and manufacturing issues